Secor Capital Advisors’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Secor Capital Advisors’s Portfolio PTLA Stock Details PTLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-55,595	Closed	-$1.26M	–	670
2016 Q3	$1.26M	Buy	+55,595	New	+$1.3M	0.14%	220
2015 Q3	–	Sell	-4,768	Closed	-$217K	–	657
2015 Q2	$217K	Buy	+4,768	New	+$192K	0.08%	360
2015 Q1	–	Sell	-19,325	Closed	-$547K	–	578
2014 Q4	$547K	Buy	19,325 +1,905	+11%	+$53K	0.23%	164
2014 Q3	$440K	Buy	17,420 +4,810	+38%	+$127K	0.25%	146
2014 Q2	$368K	Buy	+12,610	New	+$305K	0.19%	182

Other funds holding PTLA

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

SAM

Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Secor Capital Advisors's PTLA Position: Q4 2016 in Review

Secor Capital Advisors sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q4 2016, closing a stake of 55,595 shares — an estimated $1.26M sold.

Secor Capital Advisors first reported a position in PTLA in Q2 2014 and held it in 5 quarters. The position peaked at $1.26M in Q3 2016. 150 funds tracked by Wall St. Rank hold PTLA as of Q4 2016.

Secor Capital Advisors reported no remaining Portola Pharmaceuticals, Inc. position as of Q4 2016 after selling out during the quarter.
Secor Capital Advisors sold 55,595 Portola Pharmaceuticals, Inc. shares in Q4 2016, an estimated $1.26M.
Secor Capital Advisors first reported a position in Portola Pharmaceuticals, Inc. in Q2 2014 and held it in 5 quarters.
Secor Capital Advisors's Portola Pharmaceuticals, Inc. position peaked at $1.26M in Q3 2016.
150 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q4 2016.

Based on Secor Capital Advisors's 13F filing for Q4 2016, filed 14 Feb 2017.